D.E. Shaw & Co
HELP

D.E. Shaw & Co’s Helus Pharma Inc. Common Stock HELP Stock Holding History

D.E. Shaw & Co’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$408K Buy
+61,782
New +$309K ﹤0.01% 4275

Other funds holding HELP

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

D.E. Shaw & Co's HELP Position: Q2 2026 in Review

D.E. Shaw & Co opened a new position in Helus Pharma Inc. Common Stock (HELP) in Q2 2026: 61,782 shares worth $408K. The stake represents ﹤0.01% of the portfolio and ranks #4275 among its holdings.

99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

  • D.E. Shaw & Co held 61,782 shares of Helus Pharma Inc. Common Stock worth $408K as of Q2 2026.
  • Helus Pharma Inc. Common Stock was a new D.E. Shaw & Co position in Q2 2026.
  • Helus Pharma Inc. Common Stock made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #4275 holding.
  • 99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.